PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsMarinus Pharmaceuticals
Marinus Pharmaceuticals(MRNS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
ZtalmyGanaxolone2022-06-012026-2037
Infantile spasms
,
Seizures
,
Epileptic syndromes
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ganaxolone
depression
,
depressive disorder
,
pregnancy complications
,
postpartum depression
,
puerperal disorders
,
mood disorders
,
mental disorders
,
behavioral symptoms
,
partial epilepsies
,
spasm
,
infantile spasms
,
smoking cessation
,
postpartum period
,
fragile x syndrome
,
syndrome
,
post-traumatic stress disorders
,
traumatic stress disorders
,
complex partial epilepsy
,
muscle cramp
,
epilepsy
,
status epilepticus
,
tuberous sclerosis
,
sclerosis
,
seizures
,
drug resistant epilepsy
,
treatment-resistant depressive disorder
,
major depressive disorder
Alfacalcidol
erectile dysfunction
Lotamilast
recurrence
,
carcinoma
,
ovarian neoplasms
,
serous cystadenocarcinoma
,
fallopian tube neoplasms
,
carcinosarcoma
,
hereditary breast and ovarian cancer syndrome
,
mullerian mixed tumor
Remetinostat
hyperlipoproteinemia type i
Sepranolone
epilepsy
,
complex partial epilepsy
Usistapide
hyperlipoproteinemia type i
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use